Healthcare & Medical Devices Global On demand · 24-48h

Global Whole Blood Bag System Market Strategic Research Report

Global Whole Blood Bag System Market Strategic Research Repo…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Whole Blood Bag System Market
$8022025
6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Single Blood Bag System, Double Blood Bag System, Triple Blood Bag System, Quadruple Blood Bag System

By Application: Hospital Blood Banks, Regional Blood Centers, Mobile Blood Collection Units, Clinical Research Use, Public Health Blood Programs

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Terumo BCT, Inc., Safetran BioMedical Inc., Macopharma, WEGO Medical, Genesis BPS, JMS, Polymed Medical Devices, MIMS Euro, Mitra, HLL, Nigale

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 118 pages
Market size 2025
$802
Million USD
Forecast CAGR
6%
2025-2032
Forecast 2032
$1205.9
Projected
Regionen
5
Asia Pacific · Latin America · MEA · Europe · North America

Übersicht

Scope of the Report

The global Whole Blood Bag System market size is predicted to grow from US$ 802 million in 2025 to US$ 1,207 million in 2032; it is expected to grow at a CAGR of 6.0% from 2026 to 2032.

A whole blood bag system is a disposable sterile medical device used for collecting, storing, and transporting whole blood from donors. It typically consists of medical-grade plastic blood bags, anticoagulant solution, tubing, and connecting components. This system effectively prevents contamination and maintains blood quality, and is widely used in transfusion therapy in hospitals and blood centers. The whole blood bag system industry chain includes upstream medical-grade PVC or polymer film, anticoagulant solution, plastic tubing, blood collection needles, and packaging materials. Midstream involves system assembly, sterilization, quality testing, and labeling. Downstream applications cover blood banks, hospitals, emergency centers, and transfusion service providers. Supporting services include regulatory compliance, cold chain logistics, inventory management, and post-market surveillance to ensure blood safety, traceability, and a stable supply. In 2025, global production of whole blood bag systems was approximately 6.83 million units, with a global average market price of approximately US$120 per unit. The gross profit margin of major companies in the industry ranged from 35% to 55%. In 2025, global production capacity of whole blood bag systems was approximately 9.11 million units.

Global key Whole Blood Bag System players cover Terumo BCT, Inc., Safetran BioMedical Inc., Macopharma, WEGO Medical, Genesis BPS, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Whole Blood Bag System market?

What factors are driving Whole Blood Bag System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Whole Blood Bag System market opportunities vary by end market size?

How does Whole Blood Bag System break out by Type, by Application?

This report presents a comprehensive overview of the global Whole Blood Bag System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Single Blood Bag System
  • Double Blood Bag System
  • Triple Blood Bag System
  • Quadruple Blood Bag System

Segment by Anticoagulant Solution

  • CPD Blood Bag
  • CPDA-1 Blood Bag
  • ACD Blood Bag

Segment by Application

  • Hospital Blood Banks
  • Regional Blood Centers
  • Mobile Blood Collection Units
  • Clinical Research Use
  • Public Health Blood Programs

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Whole Blood Bag System market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital Blood Banks, Regional Blood Centers, Mobile Blood Collection Units evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Whole Blood Bag System Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$802
2025
Forecast
$1205.9
2032
CAGR
6%
2025–2032
Regionen
5
global
Key companies
Terumo BCT, Inc.Safetran BioMedical Inc.MacopharmaWEGO MedicalGenesis BPSJMSPolymed Medical DevicesMIMS Euro
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Single Blood Bag SystemDouble Blood Bag SystemTriple Blood Bag SystemQuadruple Blood Bag System
By Application
Hospital Blood BanksRegional Blood CentersMobile Blood Collection UnitsClinical Research UsePublic Health Blood Programs

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Single Blood Bag System
  • 3.1.3 Double Blood Bag System
  • 3.1.4 Triple Blood Bag System
  • 3.1.5 Quadruple Blood Bag System
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital Blood Banks
  • 4.1.3 Regional Blood Centers
  • 4.1.4 Mobile Blood Collection Units
  • 4.1.5 Clinical Research Use
  • 4.1.6 Public Health Blood Programs
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Terumo BCT, Inc.
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Safetran BioMedical Inc.
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Macopharma
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 WEGO Medical
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Genesis BPS
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 JMS
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Polymed Medical Devices
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 MIMS Euro
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Mitra
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 HLL
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Nigale
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Whole Blood Bag System market size?
The global Whole Blood Bag System market is estimated at US$ 802 million in 2025 (base year) and is projected to reach US$ 1.21 billion by 2032.
What growth rate is expected for the Whole Blood Bag System market through 2032?
The market is expected to grow at a CAGR of 6.0% from 2026 to 2032, expanding from US$ 802 million in 2025 to US$ 1.21 billion in 2032, roughly 1.5 times its base-year value.
How is Whole Blood Bag System defined?
A whole blood bag system is a disposable sterile medical device used for collecting, storing, and transporting whole blood from donors. It typically consists of medical-grade plastic blood bags, anticoagulant solution, tubing, and connecting components. This system effectively prevents contamination and maintains blood quality, and is widely used in transfusion therapy in hospitals and blood centers.
How is the Whole Blood Bag System market segmented by type?
By type, the market is segmented into Single Blood Bag System, Double Blood Bag System, Triple Blood Bag System and Quadruple Blood Bag System.
What are the key applications of Whole Blood Bag System?
Key applications covered include Hospital Blood Banks, Regional Blood Centers, Mobile Blood Collection Units, Clinical Research Use and Public Health Blood Programs.
Which companies are profiled in the Whole Blood Bag System market report?
Key players profiled include Terumo BCT, Safetran BioMedical Inc., Macopharma, WEGO Medical, Genesis BPS, JMS, Polymed Medical Devices and MIMS Euro, among 11 companies covered in total.
What geographies does the Whole Blood Bag System market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Whole Blood Bag System?
What factors are driving Whole Blood Bag System market growth, globally and by region?
Who should buy the Whole Blood Bag System market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital Blood Banks, Regional Blood Centers and Mobile Blood Collection Units, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Whole Blood Bag System market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.